PRINCETON PREMIUM FUND
Class | A | Shares | PPFAX |
Class | I | Shares | PPFIX |
Supplement dated August 15, 2025
to the Prospectus and Statement of Additional Information
(“SAI”) dated
______________________________________________________________________
The Fund’s fee and expenses table and expense example on page 1 of the Fund’s prospectus is hereby restated as follows:
This table describes the fees and expenses that you
may pay if you buy, hold and sell shares of the Fund. You may pay other fees, such as brokerage commissions and other fees to financial
intermediaries, which are not reflected in the tables and examples below.
Shareholder Fees (fees paid directly from your investment) |
Class A | Class I |
Maximum Sales Charge (Load) Imposed on Purchases (as a % of offering price) |
||
Maximum Deferred Sales Charge (Load) | ||
Maximum Sales Charge (Load) Imposed on Reinvested Dividends and other Distributions | ||
Redemption Fee |
Annual Fund Operating Expenses (expenses that you pay each year as a percentage of the value of your investment) |
||
Management Fees | ||
Distribution and/or Service (12b-1) Fees | ||
Other Expenses(1) | ||
Acquired Fund Fees and Expenses(2) | ||
Total Annual Fund Operating Expenses | ||
Fee Waiver and/or Expense Reimbursement(3) | ( |
( |
Total Annual Fund Operating Expenses After Fee Waiver and/or Expenses Reimbursement |
(1) |
(2) |
(3) |
This Example is intended to help you compare the cost of investing in the Fund with the cost of investing in other mutual funds.
Class | 1 Year | 3 Years | 5 Years | 10 Years |
Class A | $ |
$ |
$ |
$ |
Class I | $ |
$ |
$ |
$ |
You should read this Supplement in conjunction with the Prospectus and SAI for the Fund dated January 28, 2025. These documents provide information that you should know about the Fund before investing and have been filed with the Securities and Exchange Commission. These documents are available upon request and without charge by calling the Fund toll-free at 1-888-868-9501. Please retain this Supplement for future reference.
Please retain this Supplement for future reference.